LYTIR

Insider · SEC Form 4 · President

Jaen Juan C.

In the 12 months to Nov 8, 2026, on the open market: sold $2.9M of RCUS. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.9M in total.Jun: Insider sales $878KJul: Insider sales $2.0MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. RCUSSold: Arcus Biosciences, Inc. Jul 10, 2026 20,067 shares filed Jul 13, 2026 2 transactions 10b5-1 plan filing $574K
  2. RCUSSold: Arcus Biosciences, Inc. Jul 9, 2026 48,502 shares filed Jul 13, 2026 842,307 shares held indirectly after, as filed 10b5-1 plan filing $1.5M
  3. RCUSSold: Arcus Biosciences, Inc. Jun 24, 2026 6,431 shares filed Jun 24, 2026 890,809 shares held indirectly after, as filed 10b5-1 plan filing $191K
  4. RCUSSold: Arcus Biosciences, Inc. Jun 23, 2026 15,764 shares filed Jun 24, 2026 2 transactions 10b5-1 plan filing $437K
  5. RCUSSold: Arcus Biosciences, Inc. Jun 22, 2026 9,236 shares filed Jun 24, 2026 913,004 shares held indirectly after, as filed 10b5-1 plan filing $250K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.